CPC A61K 38/2086 (2013.01) [A61K 38/1793 (2013.01); A61K 39/39558 (2013.01); A61K 47/6425 (2017.08); A61P 35/00 (2018.01); A61K 39/04 (2013.01); C07K 14/35 (2013.01); C07K 14/5443 (2013.01); C07K 14/7155 (2013.01); C07K 16/2818 (2013.01); C07K 16/2827 (2013.01); C07K 16/2887 (2013.01); C07K 16/2896 (2013.01); C07K 16/32 (2013.01); C07K 2317/732 (2013.01); C07K 2319/30 (2013.01); C07K 2319/32 (2013.01)] | 23 Claims |
1. A method for treating a neoplasia. in a subject, the method comprising: administering to said subject an effective amount of an isolated anti-CD38 antibody and an effective amount of a pharmaceutical composition comprising an IL-15:IL-15RαSu complex, wherein the effective amount of the IL-15:IL-15RαSu complex is between 0.1 μg/kg and 100 mg/kg, thereby treating the neoplasia.
|